Drug Discovery Technologies Market
Drug Discovery Technologies Market Analysis By Drug Type (Small Molecule & Biologic Drugs) By Technology (High Throughput Screening, Genomics, Biochips, Pharmacogenomics, Bioanalytical Instruments, Bioinformatics & Nanotechnology) By End-User & Region – Global Market Insights 2022 to 2026
Analysis of Drug Discovery Technologies market covering 30 + countries including analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
Drug Discovery Technologies Market Outlook (2022 to 2026)
The global drug discovery technologies market accounts for a revenue of US$ 59 billion in 2022, which is expected to increase to US$ 81.5 billion by the end of 2026. This is because worldwide demand for drug discovery technologies is anticipated to surge at a CAGR of 8.4% from 2022 to 2026.
The China drug discovery technologies market is projected to reach US$ 12 billion by 2026, expanding at a stellar CAGR of around 10% over the forecast period.
| Report Attributes | Details |
|---|---|
| Market Size (2022) | US$ 59 Billion |
| Projected Market Value (2026F) | US$ 81.5 Billion |
| Global Market Growth Rate (2022 to 2026) | 8.4% CAGR |
| China Market Value (2026F) | US$ 12 Billion |
| United States Market Value (2022) | US$ 17 Billion |
| Germany Market Growth Rate (2022 to 2026) | 7% CAGR |
| Key Companies Profiled | Arqule; Abbott Laboratories; Thermo Fisher Scientific Inc.; Merck KGaA; Albany Molecular Research; Celera Corp; Charles River Laboratories International; Molecular Discovery Ltd.; Bio-Rad Laboratories; Caliper Life Sciences; Evotec Ag; Gyros AbIncyte Corp.; Novartis AG; Affymetrix Inc.; Agilent Technologies Inc. |
Don't Need a Global Report?
save 40%! on Country & Region specific reports
Revenue Analysis of Drug Discovery Technologies (2017 to 2021) in Comparison to Market Growth Forecasts (2022 to 2026)
Rising focus on healthcare has resulted in increased consumption of pharmaceutical drugs and has created high demand for these medications across the world. This demand is supplemented by the prevalence of chronic diseases and subsequently propels the drug discovery technologies market potential.
Increasing investments in R&D activities, supportive government initiatives to promote drug development, growing incidence of chronic illnesses, and rapid technological advancements are expected to be major factors that positively influence the drug discovery technologies market growth throughout the forecast period.
The aforementioned factors are also expected to supplement the demand for drug discovery services through 2026. However, high costs and the presence of strict regulatory laws for drug development are expected to have a hampering effect on the overall demand for drug discovery technologies over the next four years.
The drug discovery technologies market, from 2022 to 2026, is slated to exhibit evolution at a high CAGR of 8.4%.
What Factor is Majorly Driving Drug Discovery Technologies Market Growth?
“Rising Incidence of Chronic Illnesses across the World”
Over the past few years, the world has witnessed a notable increase in the incidence of chronic diseases and this has led to heightened demand for drugs and subsequently uplifted the drug discovery technologies market potential.
The prevalence of chronic diseases is projected to increase across the forecast period as well and is expected to prominently favor drug discovery technologies market growth.
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
How is Technology Driving the Future of Drug Development?
“Technological Advancements Resulting in Better Drug Discovery Opportunities”
Drug development is a crucial and time-consuming process that is being revolutionized by the use of advanced technologies.
Advancements in technologies are now creating more efficient drug discovery platforms that fast-track the drug development cycle and enable drug manufacturers to create effective drugs in a shorter period than conventional methods.
What’s Constraining Demand for Drug Discovery Technologies?
“High Costs & Long Duration of Drug Discovery Process”
The drug discovery process involves a lot of time and capital investment which makes it an expensive process to carry out and this is anticipated to be the major factor that hinders overall drug discovery technologies market growth over the coming years.
Moreover, stringent regulatory mandates regarding drug development in various regions are also projected to have a restraining effect on the overall drug discovery technologies market potential through 2026.
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
How Can Upcoming Market Players Make a Mark in the Global Drug Discovery Technologies Industry?
“Start-ups Can Focus on Expanding their Research Scope through New Funding”
- In July 2022, Nuclera, a biotechnology start-up, raised US$ 58 million in a Series B funding round. The funding will be used to further advance the development of its eProtein 3D bioprinter, which is expected to accelerate and democratize the drug discovery process.
- In July 2022, Martin Shkreli, a former pharmaceutical company executive, launched a new company called Druglike. The company is centered on a Web3 drug discovery platform that is aimed at reducing the overall cost of the drug development process.
- Vicinitas Therapeutics, a start-up focused on protein stabilization, launched a technology to remove the molecular tags that break down beneficial proteins, thereby resulting in stabilized protein and better drug development possibilities. The start-up has raised around US$ 65 million until now from its investors to bolster its research capabilities.
Aspiring market players can focus on innovations in drug discovery technology to create a market presence for themselves. Blockchain in drug discovery is expected to be a popular trend that start-ups could focus on as digitization picks up pace across the world.
The AI drug discovery industry is expected to provide lucrative opportunities for new drug discovery technology providers over the years as the use of artificial intelligence in drug development becomes mainstream.
Which Region Spearheads Revenue Generation for Drug Discovery Technologies?
“Drug Discovery Technologies Market Majorly Driven by North America”
The market for drug discovery technologies in North America is anticipated to be the most lucrative one in the global landscape owing to high research and development activity in this region.
High spending on pharmaceuticals in this region is expected to further bolster the drug discovery technologies market potential in this region across the forecast period. The United States is expected to head drug discovery technologies market growth for this region through 2026. Automation in drug discovery is anticipated to emerge as a popular trend over the coming years in North America.
Increasing collaborations and mergers by drug discovery platform providers in the region of Europe are anticipated to favor drug discovery technologies market growth in the region throughout the forecast period. Germany drug discovery technologies market is projected to witness expansion at a CAGR of around 7% over the years to come. Other notable markets in Europe are expected to be France, Italy, and the United Kingdom.
Asia Pacific region is anticipated to exhibit highly lucrative opportunities for drug manufacturers and drug manufacturers owing to less stringent mandates for drug development and supportive initiatives to boost research and development activities in this region. The region is also expected to be lucrative for the drug discovery outsourcing market through 2026.
Increasing focus on healthcare and the rising prevalence of chronic diseases in this region is expected to further propel drug discovery technologies market growth through 2026. China and India are anticipated to be the leading markets to watch out for in this region throughout the forecast period.
This new drug discovery technologies market research report by analysts at Fact.MR, a market research and competitive intelligence provider has a detailed account of all trends impacting drug development on a regional as well as global level through 2026.
Country-wise Insights
Why is the United States an Opportune Market?
“Rising Investments in R&D of Novel Drugs”
The market for drug discovery technologies in the United States is projected to be a highly opportunistic one for drug discovery companies owing to the rising demand for novel drugs and supportive government initiatives to boost research and development activities.
Fast drug approval and the presence of key drug development organizations in the country are also expected to favor drug discovery technologies market potential over the coming years. DNA technology in drug development is expected to increase in popularity in the country over the coming years.
At present, the United States drug discovery technologies market accounts for a revenue total of US$ 17 billion.
Category-wise Insights
Which Type of Drug is Expected to Witness Higher Demand?
“Biologic Drugs Projected to Lead Overall Market Growth”
The global drug discovery technologies market based on drug type is segmented into small molecule drugs and biologic drugs.
The biologic drugs segment is anticipated to account for a major market share going forward owing to the increasing adoption of biologics in drug development. Target specificity of biologics is a major factor that is predicted to drive the growth of the biologic drugs segment over the coming years.
Other benefits such as fewer side effects, potential to cure diseases, and potent action are also expected to favor demand for biologic drugs across the forecast period. Small molecule drugs are projected to witness a steady rise in demand as advancements for their development pick up pace through 2026.
Competitive Landscape
Companies in the drug discovery technologies market are expected to focus on launching new solutions to enhance drug discovery and drug development.
- In July 2022, Dotmatics, an R&D scientific software organization, announced the release of its new Chemistry Solution for Small Molecule Drug Discovery. The new solution is a compilation of workflows, R&D applications, and the company’s enterprise scientific platform to provide best practices for small molecule drug discovery and development.
Segments of Drug Discovery Technologies Industry Research
-
By Drug Type :
- Small Molecule Drugs
- Biologic Drugs
-
By Technology :
- High Throughput Screening
- Genomics
- Biochips
- Pharmacogenomics
- Bioanalytical Instruments
- Bioinformatics
- Nanotechnology in Drug Discovery
- Other Technologies
-
By End User :
- Pharmaceutical Companies
- Biopharmaceutical Companies
- Biotechnology Companies
- Research Institutes
- Other End Users
-
By Region :
- North America
- Latin America
- Europe
- East Asia
- South Asia & Oceania
- MEA
Table of Content
- 1. Global Market - Executive Summary
- 2. Global Market Overview
- 3. Market Risks and Trends Assessment
- 4. Market Background and Foundation Data Points
- 5. Global Market Demand (US$ Mn) Analysis 2017 to 2021 and Forecast, 2022 to 2026
- 6. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2026, By Technology
- 6.1. High Throughput Screening
- 6.2. Genomics
- 6.3. Biochips
- 6.4. Pharmacogenomics
- 6.5. Bioanalytical Instruments
- 6.6. Bioinformatics
- 6.7. Nanotechnology in Drug Discovery
- 6.8. Other Technologies
- 7. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2026, by Drug Type
- 7.1. Small Molecule Drugs
- 7.2. Biologic Drugs
- 8. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2026, by End User
- 8.1. Pharmaceutical Companies
- 8.2. Biopharmaceutical Companies
- 8.3. Biotechnology Companies
- 8.4. Research Institutes
- 8.5. Other End Users
- 9. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2026, by Region
- 9.1. North America
- 9.2. Latin America
- 9.3. Europe
- 9.4. East Asia
- 9.5. South Asia & Oceania
- 9.6. Middle East and Africa (MEA)
- 10. North America Market Analysis 2017 to 2021 and Forecast 2022 to 2026
- 11. Latin America Market Analysis 2017 to 2021 and Forecast 2022 to 2026
- 12. Europe Market Analysis 2017 to 2021 and Forecast 2022 to 2026
- 13. East Asia Market Analysis 2017 to 2021 and Forecast 2022 to 2026
- 14. South Asia & Oceania Market Analysis 2017 to 2021 and Forecast 2022 to 2026
- 15. Middle East and Africa Market Analysis 2017 to 2021 and Forecast 2022 to 2026
- 16. Market Structure Analysis
- 17. Competition Analysis
- 17.1. Arqule
- 17.2. Abbott Laboratories
- 17.3. Thermo Fisher Scientific Inc.
- 17.4. Merck KGaA
- 17.5. Albany Molecular Research
- 17.6. Celera Corp
- 17.7. Charles River Laboratories International
- 17.8. Molecular Discovery Ltd.
- 17.9. Bio-Rad Laboratories
- 17.10. Caliper Life Sciences
- 17.11. Evotec Ag
- 17.12. Gyros AbIncyte Corp.
- 17.13. Novartis AG
- 17.14. Affymetrix Inc.
- 17.15. Agilent Technologies Inc.
- 18. Assumptions And Acronyms Used
- 19. Research Methodology
Don't Need a Global Report?
save 40%! on Country & Region specific reports
List Of Table
Table 01: Global Market Value (US$ Mn) Analysis, by Technology, 2017 to 2021
Table 02: Global Market Value (US$ Mn) Analysis, by Technology, 2022 to 2026
Table 03: Global Market Value (US$ Mn) Opportunity Analysis, by Technology, 2022 to 2026
Table 04: Global Market Value (US$ Mn) Analysis, by Drug Type, 2017 to 2021
Table 05: Global Market Value (US$ Mn) Analysis, by Drug Type, 2022 to 2026
Table 06: Global Market Value (US$ Mn) Opportunity Analysis, by Drug Type, 2022 to 2026
Table 07: Global Market Value (US$ Mn) Analysis, by End User, 2017 to 2021
Table 08: Global Market Value (US$ Mn) Analysis, by End User, 2022 to 2026
Table 09: Global Market Value (US$ Mn) Opportunity Analysis, by End User, 2022 to 2026
Table 10: Global Market Value (US$ Mn) Analysis, by Region, 2017 to 2021
Table 11: Global Market Value (US$ Mn) Analysis, by Region, 2022 to 2026
Table 12: Global Market Value (US$ Mn) Opportunity Analysis, by Region, 2022 to 2026
Table 13: North America Market Value (US$ Mn) Analysis, by Country, 2017 to 2021
Table 14: North America Market Value (US$ Mn) Analysis, by Country, 2022 to 2026
Table 15: North America Market Value (US$ Mn) Opportunity Analysis, by Country, 2022 to 2026
Table 16: North America Market Value (US$ Mn) Analysis, by Technology, 2017 to 2021
Table 17: North America Market Value (US$ Mn) Analysis, by Technology, 2022 to 2026
Table 18: North America Market Value (US$ Mn) Opportunity Analysis, by Technology, 2022 to 2026
Table 19: North America Market Value (US$ Mn) Analysis, by Drug Type, 2017 to 2021
Table 20: North America Market Value (US$ Mn) Analysis, by Drug Type, 2022 to 2026
Table 21: North America Market Value (US$ Mn) Opportunity Analysis, by Drug Type, 2022 to 2026
Table 22: North America Market Value (US$ Mn) Analysis, by End User, 2017 to 2021
Table 23: North America Market Value (US$ Mn) Analysis, by End User, 2022 to 2026
Table 24: North America Market Value (US$ Mn) Opportunity Analysis, by End User, 2022 to 2026
Table 25: Latin America Market Value (US$ Mn) Analysis, by Country, 2017 to 2021
Table 26: Latin America Market Value (US$ Mn) Analysis, by Country, 2022 to 2026
Table 27: Latin America Market Value (US$ Mn) Opportunity Analysis, by Country, 2022 to 2026
Table 28: Latin America Market Value (US$ Mn) Analysis, by Technology, 2017 to 2021
Table 29: Latin America Market Value (US$ Mn) Analysis, by Technology, 2022 to 2026
Table 30: Latin America Market Value (US$ Mn) Opportunity Analysis, by Technology, 2022 to 2026
Table 31: Latin America Market Value (US$ Mn) Analysis, by Drug Type, 2017 to 2021
Table 32: Latin America Market Value (US$ Mn) Analysis, by Drug Type, 2022 to 2026
Table 33: Latin America Market Value (US$ Mn) Opportunity Analysis, by Drug Type, 2022 to 2026
Table 34: Latin America Market Value (US$ Mn) Analysis, by End User, 2017 to 2021
Table 35: Latin America Market Value (US$ Mn) Analysis, by End User, 2022 to 2026
Table 36: Latin America Market Value (US$ Mn) Opportunity Analysis, by End User, 2022 to 2026
Table 37: Europe Market Value (US$ Mn) Analysis, by Country, 2017 to 2021
Table 38: Europe Market Value (US$ Mn) Analysis, by Country, 2022 to 2026
Table 39: Europe Market Value (US$ Mn) Opportunity Analysis, by Country, 2022 to 2026
Table 40: Europe Market Value (US$ Mn) Analysis, by Technology, 2017 to 2021
Table 41: Europe Market Value (US$ Mn) Analysis, by Technology, 2022 to 2026
Table 42: Europe Market Value (US$ Mn) Opportunity Analysis, by Technology, 2022 to 2026
Table 43: Europe Market Value (US$ Mn) Analysis, by Drug Type, 2017 to 2021
Table 44: Europe Market Value (US$ Mn) Analysis, by Drug Type, 2022 to 2026
Table 45: Europe Market Value (US$ Mn) Opportunity Analysis, by Drug Type, 2022 to 2026
Table 46: Europe Market Value (US$ Mn) Analysis, by End User, 2017 to 2021
Table 47: Europe Market Value (US$ Mn) Analysis, by End User, 2022 to 2026
Table 48: Europe Market Value (US$ Mn) Opportunity Analysis, by End User, 2022 to 2026
Table 49: East Asia Market Value (US$ Mn) Analysis, by Country, 2017 to 2021
Table 50: East Asia Market Value (US$ Mn) Analysis, by Country, 2022 to 2026
Table 51: East Asia Market Value (US$ Mn) Opportunity Analysis, by Country, 2022 to 2026
Table 52: East Asia Market Value (US$ Mn) Analysis, by Technology, 2017 to 2021
Table 53: East Asia Market Value (US$ Mn) Analysis, by Technology, 2022 to 2026
Table 54: East Asia Market Value (US$ Mn) Opportunity Analysis, by Technology, 2022 to 2026
Table 55: East Asia Market Value (US$ Mn) Analysis, by Drug Type, 2017 to 2021
Table 56: East Asia Market Value (US$ Mn) Analysis, by Drug Type, 2022 to 2026
Table 57: East Asia Market Value (US$ Mn) Opportunity Analysis, by Drug Type, 2022 to 2026
Table 58: East Asia Market Value (US$ Mn) Analysis, by End User, 2017 to 2021
Table 59: East Asia Market Value (US$ Mn) Analysis, by End User, 2022 to 2026
Table 60: East Asia Market Value (US$ Mn) Opportunity Analysis, by End User, 2022 to 2026
Table 61: South Asia & Oceania Market Value (US$ Mn) Analysis, by Country, 2017 to 2021
Table 62: South Asia & Oceania Market Value (US$ Mn) Analysis, by Country, 2022 to 2026
Table 63: South Asia & Oceania Market Value (US$ Mn) Opportunity Analysis, by Country, 2022 to 2026
Table 64: South Asia & Oceania Market Value (US$ Mn) Analysis, by Technology, 2017 to 2021
Table 65: South Asia & Oceania Market Value (US$ Mn) Analysis, by Technology, 2022 to 2026
Table 66: South Asia & Oceania Market Value (US$ Mn) Opportunity Analysis, by Technology, 2022 to 2026
Table 67: South Asia & Oceania Market Value (US$ Mn) Analysis, by Drug Type, 2017 to 2021
Table 68: South Asia & Oceania Market Value (US$ Mn) Analysis, by Drug Type, 2022 to 2026
Table 69: South Asia & Oceania Market Value (US$ Mn) Opportunity Analysis, by Drug Type, 2022 to 2026
Table 70: South Asia & Oceania Market Value (US$ Mn) Analysis, by End User, 2017 to 2021
Table 71: South Asia & Oceania Market Value (US$ Mn) Analysis, by End User, 2022 to 2026
Table 72: South Asia & Oceania Market Value (US$ Mn) Opportunity Analysis, by End User, 2022 to 2026
Table 73: MEA Market Value (US$ Mn) Analysis, by Country, 2017 to 2021
Table 74: MEA Market Value (US$ Mn) Analysis, by Country, 2022 to 2026
Table 75: MEA Market Value (US$ Mn) Opportunity Analysis, by Country, 2022 to 2026
Table 76: MEA Market Value (US$ Mn) Analysis, by Technology, 2017 to 2021
Table 77: MEA Market Value (US$ Mn) Analysis, by Technology, 2022 to 2026
Table 78: MEA Market Value (US$ Mn) Opportunity Analysis, by Technology, 2022 to 2026
Table 79: MEA Market Value (US$ Mn) Analysis, by Drug Type, 2017 to 2021
Table 80: MEA Market Value (US$ Mn) Analysis, by Drug Type, 2022 to 2026
Table 81: MEA Market Value (US$ Mn) Opportunity Analysis, by Drug Type, 2022 to 2026
Table 82: MEA Market Value (US$ Mn) Analysis, by End User, 2017 to 2021
Table 83: MEA Market Value (US$ Mn) Analysis, by End User, 2022 to 2026
Table 84: MEA Market Value (US$ Mn) Opportunity Analysis, by End User, 2022 to 2026
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
List Of Figures
Figure 01: Global Market Value (US$ Mn) Historical Analysis, 2017 to 2021
Figure 02: Global Market Value (US$ Mn) Forecast and Analysis, 2022 to 2026
Figure 03: Global Market Value Y-o-Y Growth and Forecast, 2017 to 2026
Figure 04: Global Market Incremental $ Opportunity, 2022 to 2026
Figure 05: Global Market Share and BPS Analysis by Technology, 2022 & 2026
Figure 06: Global Market Y-o-Y Growth Projections by Technology, 2022 to 2026
Figure 07: Global Market Attractiveness Analysis by Technology, 2022 to 2026
Figure 08: Global Market Share and BPS Analysis by Drug Type, 2022 & 2026
Figure 09: Global Market Y-o-Y Growth Projections by Drug Type, 2022 to 2026
Figure 10: Global Market Attractiveness Analysis by Drug Type, 2022 to 2026
Figure 11: Global Market Share and BPS Analysis by End User, 2022 & 2026
Figure 12: Global Market Y-o-Y Growth Projections by End User, 2022 to 2026
Figure 13: Global Market Attractiveness Analysis by End User, 2022 to 2026
Figure 14: Global Market Share and BPS Analysis by Region, 2022 & 2026
Figure 15: Global Market Y-o-Y Growth Projections by Region, 2022 to 2026
Figure 16: Global Market Attractiveness Analysis by Region, 2022 to 2026
Figure 17: North America Market Value (US$ Mn) Historical Analysis, 2017 to 2021
Figure 18: North America Market Value (US$ Mn) Forecast and Analysis, 2022 to 2026
Figure 19: North America Market Value Y-o-Y Growth and Forecast, 2022 to 2026
Figure 20: North America Market Incremental $ Opportunity, 2022 to 2026
Figure 21: North America Market Share Analysis by Country, 2022 & 2026
Figure 22: North America Market Y-o-Y Growth Projection by Country, 2022 to 2026
Figure 23: North America Market Attractiveness Analysis by Country, 2022 to 2026
Figure 24: North America Market Share and BPS Analysis by Technology, 2022 & 2026
Figure 25: North America Market Y-o-Y Growth Projections by Technology, 2022 to 2026
Figure 26: North America Market Attractiveness Analysis by Technology, 2022 to 2026
Figure 27: North America Market Share and BPS Analysis by Drug Type, 2022 & 2026
Figure 28: North America Market Y-o-Y Growth Projections by Drug Type, 2022 to 2026
Figure 29: North America Market Attractiveness Analysis by Drug Type, 2022 to 2026
Figure 30: North America Market Share and BPS Analysis by End User, 2022 & 2026
Figure 31: North America Market Y-o-Y Growth Projections by End User, 2022 to 2026
Figure 32: North America Market Attractiveness Analysis by End User, 2022 to 2026
Figure 33: Latin America Market Value (US$ Mn) Historical Analysis, 2017 to 2021
Figure 34: Latin America Market Value (US$ Mn) Forecast and Analysis, 2022 to 2026
Figure 35: Latin America Market Value Y-o-Y Growth and Forecast, 2017 to 2026
Figure 36: Latin America Market Incremental $ Opportunity, 2022 to 2026
Figure 37: Latin America Market Share Analysis by Country, 2022 & 2026
Figure 38: Latin America Market Y-o-Y Growth Projection by Country, 2022 to 2026
Figure 39: Latin America Market Attractiveness Analysis by Country, 2022 to 2026
Figure 40: Latin America Market Share and BPS Analysis by Technology, 2022 & 2026
Figure 41: Latin America Market Y-o-Y Growth Projections by Technology, 2022 to 2026
Figure 42: Latin America Market Attractiveness Analysis by Technology, 2022 to 2026
Figure 43: Latin America Market Share and BPS Analysis by Drug Type, 2022 & 2026
Figure 44: Latin America Market Y-o-Y Growth Projections by Drug Type, 2022 to 2026
Figure 45: Latin America Market Attractiveness Analysis by Drug Type, 2022 to 2026
Figure 46: Latin America Market Share and BPS Analysis by End User, 2022 & 2026
Figure 47: Latin America Market Y-o-Y Growth Projections by End User, 2022 to 2026
Figure 48: Latin America Market Attractiveness Analysis by End User, 2022 to 2026
Figure 49: Europe Market Value (US$ Mn) Historical Analysis, 2017 to 2021
Figure 50: Europe Market Value (US$ Mn) Forecast and Analysis, 2022 to 2026
Figure 51: Europe Market Value Y-o-Y Growth and Forecast, 2017 to 2026
Figure 52: Europe Market Incremental $ Opportunity, 2022 to 2026
Figure 53: Europe Market Share Analysis by Country, 2022 & 2026
Figure 54: Europe Market Y-o-Y Growth Projection by Country, 2022 to 2026
Figure 55: Europe Market Attractiveness Analysis by Country, 2022 to 2026
Figure 56: Europe Market Share and BPS Analysis by Technology, 2022 & 2026
Figure 57: Europe Market Y-o-Y Growth Projections by Technology, 2022 to 2026
Figure 58: Europe Market Attractiveness Analysis by Technology, 2022 to 2026
Figure 59: Europe Market Share and BPS Analysis by Drug Type, 2022 & 2026
Figure 60: Europe Market Y-o-Y Growth Projections by Drug Type, 2022 to 2026
Figure 61: Europe Market Attractiveness Analysis by Drug Type, 2022 to 2026
Figure 62: Europe Market Share and BPS Analysis by End User, 2022 & 2026
Figure 63: Europe Market Y-o-Y Growth Projections by End User, 2022 to 2026
Figure 64: Europe Market Attractiveness Analysis by End User, 2022 to 2026
Figure 65: East Asia Market Value (US$ Mn) Historical Analysis, 2017 to 2021
Figure 66: East Asia Market Value (US$ Mn) Forecast and Analysis, 2022 to 2026
Figure 67: East Asia Market Value Y-o-Y Growth and Forecast, 2017 to 2026
Figure 68: East Asia Market Incremental $ Opportunity, 2022 to 2026
Figure 69: East Asia Market Share Analysis by Country, 2022 & 2026
Figure 70: East Asia Market Y-o-Y Growth Projection by Country, 2022 to 2026
Figure 71: East Asia Market Attractiveness Analysis by Country, 2022 to 2026
Figure 72: East Asia Market Share and BPS Analysis by Technology, 2022 & 2026
Figure 73: East Asia Market Y-o-Y Growth Projections by Technology, 2022 to 2026
Figure 74: East Asia Market Attractiveness Analysis by Technology, 2022 to 2026
Figure 75: East Asia Market Share and BPS Analysis by Drug Type, 2022 & 2026
Figure 76: East Asia Market Y-o-Y Growth Projections by Drug Type, 2022 to 2026
Figure 77: East Asia Market Attractiveness Analysis by Drug Type, 2022 to 2026
Figure 78: East Asia Market Share and BPS Analysis by End User, 2022 & 2026
Figure 79: East Asia Market Y-o-Y Growth Projections by End User, 2022 to 2026
Figure 80: East Asia Market Attractiveness Analysis by End User, 2022 to 2026
Figure 81: South Asia & Oceania Market Value (US$ Mn) Historical Analysis, 2017 to 2021
Figure 82: South Asia & Oceania Market Value (US$ Mn) Forecast and Analysis, 2022 to 2026
Figure 83: South Asia & Oceania Market Value Y-o-Y Growth and Forecast, 2017 to 2026
Figure 84: South Asia & Oceania Market Incremental $ Opportunity, 2022 to 2026
Figure 85: South Asia & Oceania Market Share Analysis by Country, 2022 & 2026
Figure 86: South Asia & Oceania Market Y-o-Y Growth Projection by Country, 2022 to 2026
Figure 87: South Asia & Oceania Market Attractiveness Analysis by Country, 2022 to 2026
Figure 88: South Asia & Oceania Market Share and BPS Analysis by Technology, 2022 & 2026
Figure 89: South Asia & Oceania Market Y-o-Y Growth Projections by Technology, 2022 to 2026
Figure 90: South Asia & Oceania Market Attractiveness Analysis by Technology, 2022 to 2026
Figure 91: South Asia & Oceania Market Share and BPS Analysis by Drug Type, 2022 & 2026
Figure 92: South Asia & Oceania Market Y-o-Y Growth Projections by Drug Type, 2022 to 2026
Figure 93: South Asia & Oceania Market Attractiveness Analysis by Drug Type, 2022 to 2026
Figure 94: South Asia & Oceania Market Share and BPS Analysis by End User, 2022 & 2026
Figure 95: South Asia & Oceania Market Y-o-Y Growth Projections by End User, 2022 to 2026
Figure 96: South Asia & Oceania Market Attractiveness Analysis by End User, 2022 to 2026
Figure 97: MEA Market Value (US$ Mn) Historical Analysis, 2017 to 2021
Figure 98: MEA Market Value (US$ Mn) Forecast and Analysis, 2022 to 2026
Figure 99: MEA Market Value Y-o-Y Growth and Forecast, 2017 to 2026
Figure 100: MEA Market Incremental $ Opportunity, 2022 to 2026
Figure 101: MEA Market Share Analysis by Country, 2022 & 2026
Figure 102: MEA Market Y-o-Y Growth Projection by Country, 2022 to 2026
Figure 103: MEA Market Attractiveness Analysis by Country, 2022 to 2026
Figure 104: MEA Market Share and BPS Analysis by Technology, 2022 & 2026
Figure 105: MEA Market Y-o-Y Growth Projections by Technology, 2022 to 2026
Figure 106: MEA Market Attractiveness Analysis by Technology, 2022 to 2026
Figure 107: MEA Market Share and BPS Analysis by Drug Type, 2022 & 2026
Figure 108: MEA Market Y-o-Y Growth Projections by Drug Type, 2022 to 2026
Figure 109: MEA Market Attractiveness Analysis by Drug Type, 2022 to 2026
Figure 110: MEA Market Share and BPS Analysis by End User, 2022 & 2026
Figure 111: MEA Market Y-o-Y Growth Projections by End User, 2022 to 2026
Figure 112: MEA Market Attractiveness Analysis by End User, 2022 to 2026
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
- FAQs -
What is the drug discovery technologies market value at present?
Currently, the global drug discovery technologies market is valued at US$ 59 billion.
How big will the drug discovery technologies market be by 2026?
The drug discovery technologies market is projected to reach US$ 81.5 billion by 2026.
At what pace will the drug discovery technologies market evolve?
Demand for drug discovery technologies is slated to rise at 8.4% CAGR.
Which companies lead the drug discovery technologies space?
Thermo Fisher Scientific Inc., Merck KGaA, Albany Molecular Research, Celera Corp, Charles River Laboratories International, Molecular Discovery Ltd., Bio-Rad Laboratories, Caliper Life Sciences, Evotec Ag, and Gyros AbIncyte Corp are key market players.
What valuation does the U.S. drug discovery technologies market enjoy?
The U.S. drug discovery technologies market is valued at US$ 17 billion.
Drug Discovery Technologies Market